GGrantIndex
Sort

51,570 grants matching autoimmune disease

The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus

$789,602
Carla M Cuda · Northwestern University At Chicago · R01 · FY2023 · AI

Targeting microbial triggers of gammopathy for immunoprevention

$789,579
Madhav V Dhodapkar · Emory University · UG3 · FY2024 · CA

Mechanisms underlying the neuroprotective effect of nasal administration of anti-CD3 in AD mouse models

$789,540
Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2025 · AG

Characterization of the cellular and molecular bases of inborn errors of immunity

$789,400
Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Johns Hopkins Rheumatic Diseases Resource-based Core Center (Johns Hopkins RDRCC)

$789,391
Antony Rosen · Johns Hopkins University · P30 · FY2024 · AR

Aberrant DNA Repair and Lupus

$789,292
Joann B Sweasy · University Of Nebraska Medical Center · R35 · FY2025 · ES

Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis

$789,010
Luc Teyton · Scripps Research Institute, The · R01 · FY2020 · DK

MOLECULAR ANALYSIS OF AUTOANTIBODY FORMATION

$788,981
Yeshiva University · P01 · FY2001 · AI

MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes

$788,776
Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2024 · AI

Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis

$788,774
Luc Teyton · Scripps Research Institute, The · R01 · FY2021 · DK

Langerhans cells and lymphatic regulation in immunity

$788,508
Theresa T. Lu · Hospital For Special Surgery · R01 · FY2024 · AR

Infection, fever and immune signatures in an autism birth cohort

$788,507
Mady Hornig · Columbia University Health Sciences · R56 · FY2014 · NS

Early diagnosis and mechanistic studies of type 1 diabetes using single cell analysis

$788,462
Luc Teyton · Scripps Research Institute, The · R01 · FY2022 · DK

The Environmental Determinants of Diabetes in Youth: Washington Clinical Center

$788,400
William A. Hagopian · Pacific Northwest Research Institute · U01 · FY2008 · DK

Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B

$788,279
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis

$788,105
Naftali Kaminski · Yale University · R01 · FY2022 · HL

CONTROL AND ACTIVATION OF THE TUMOR NECROSIS FACTOR RECEPTORS

$788,037
James J Chou · Harvard Medical School · R01 · FY2022 · AI

LPS Signaling in Macrophages: The Role of the Toll

$787,926
Alan A Aderem · Seattle Biomedical Research Institute · R01 · FY2013 · AI

Assessment, Therapy and Prevention Of Autoimmune Disease

$787,884
Frederick Miller · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Novel DFG out inhibitors of Abl-kinases to treat PML

$787,776
Milton H. Werner · Inhibikase Therapeutics · R44 · FY2016 · AI

Determining the Intrinsic and Environmental Signal Contributing to Early T1D Progression

$787,773
Shuibing Chen · Weill Medical Coll Of Cornell Univ · U01 · FY2020 · DK

Hydrogel-based lymphoid tissues for generation of activated human B cells and delivery in vivo

$787,654
Ankur Singh · Georgia Institute Of Technology · R01 · FY2024 · AI

Assembly of MHC Class I Molecules in Vitro and in Vivo

$787,431
Hidde L Ploegh · Whitehead Institute For Biomedical Res · R01 · FY2009 · AI

The Risk of Myocardial Infarction in Patients with Psoriasis

$787,421
Joel M Gelfand · University Of Pennsylvania · R01 · FY2009 · HL

Autoantibody-Targeted Therapy for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

$787,346
Steven R Duncan · University Of Alabama At Birmingham · U01 · FY2017 · HL